Clinical Context
Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated
A study published in Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001) in 2026 evaluated clinical Findings, Treatment Recommendations, and Outcome in Dogs Following Ingestion of a Single Unintended Dose of Trilostane: 403 Cases (2008-2023)..
Key Findings
To characterize the clinical signs and outcomes in dogs following ingestion of a single, unintended dose of trilostane. The secondary objective was to describe treatment recommendations given for this population. Retrospective evaluation of cases of canine trilostane exposure from February 2008 to August 2023. Private, specialty toxicology consultation service. Four hundred three cases were selected from the American Society for the Prevention of Cruelty to Animals (ASPCA) Animal Poison Control Center AnTox database using a nonstratified sampling technique. Data included patient demographics, history, therapeutic use of trilostane, exposure...
Why It Matters for Veterinary Professionals
For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for canine patients.
Practical Interpretation
The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.
Clinical Takeaway
Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.
Read the full article here.
List
Add
Please enter a comment